Table 4.
2003/2005 Study Cohorts | |||||||
---|---|---|---|---|---|---|---|
eGFR (ml/min/1.73m2) | eGFR (ml/min/1.73m2) | eGFR (ml/min/1.73m2) | |||||
Outcomes | ≤30 (n=255) | 31–59 (n=819) | ≥60 (n=974) | ≤30 Adjusted Odds Ratio (95% CI)# | 31–59 Adjusted Odds Ratio (95% CI)# | ≤30 Adjusted Odds Ratio (95% CI)§ | 31–59 Adjusted Odds Ratio (95% CI)§ |
Length of hospital stay (mean, days) | 6.8 | 6.0 | 4.7* | 2.26 (1.61,3.19) | 1.34 (1.05,1.72) | 3.27 (2.26,4.74) | 1.40 (1.07,1.83) |
Hospital Complications (%) | |||||||
Atrial fibrillation | 29.8 | 27.6 | 16.5* | 1.31 (0.89,1.92) | 1.25 (0.95,1.65) | 1.41 (0.94,2.11) | 1.24 (0.93,1.64) |
Cardiogenic shock | 5.9 | 5.6 | 3.6 | 1.57 (0.75,3.29) | 1.38 (0.81,2.37) | 1.79 (0.81,3.95) | 1.38 (0.80,2.39) |
Heart failure | 66.3 | 51.0 | 22.8* | 3.04 (2.09,4.41) | 1.88 (1.46,2.43) | 3.09 (2.10,4.56) | 1.86 (1.44,2.41) |
Death | 21.6 | 11.2 | 4.0* | 4.48 (2.58,7.77) | 2.01 (1.24,3.24) | 2.97 (1.63,5.40) | 1.68 (1.02,2.77) |
30-day mortality | 27.8 | 16.0 | 6.1* | 3.95 (2.43,6.41) | 2.00 (1.33,2.99) | 2.73 (1.62,4.59) | 1.72 (1.13,2.63) |
P value ≤0.05
adjusted for age, sex, body mass index, prior history of: angina, hypertension, diabetes, stroke, hypercholesterolemia, heart failure, acute myocardial infarction order (initial vs prior) and acute myocardial infarction type (Q wave vs non-Q wave)
adjusted for variables included in the first multiple regression analysis as well as use of hospital cardiac medications and coronary interventional procedures
Compared to length of stay >median of 5 days